Crestor RUSH (The efficacy of RosUvaStatin for Korean dyslipidemia patients with Hypertension ) - RUSH

Study identifier:NIS-CKR-CRE-2007/2

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

RUSH (Evaluating the efficacy of RosUvaStatin for Korean dyslipidemia patients with Hypertension in real world practice)

Medical condition

Dyslipidemia

Phase

Healthy volunteers

Yes

Study drug

Sex

All

Actual Enrollment

5000

Study type

Observational

Age

18 Years +

Date

Study Start Date: 01 May 2007

Primary Completion Date: 01 Nov 2007

Study Completion Date: 01 Nov 2007

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2010 by AstraZeneca Pharmaceuticals

Collaborators

Inclusion and exclusion criteria

No locations available

Arms	Assigned Interventions

Documents available

http://www.astrazeneca.com/node/emailtriage.aspx
Download
Trial Results Summaries
Available here

Contacts

Contact

AstraZeneca Korea Clinical Study

82-2-2188-2146

[email protected]

Investigators

Principal Investigator

Hyunah Caroline Choi

AstraZeneca Korea